Osteoporosis in patients with cystic fibrosis.

[1]  Barrett T. Kitch,et al.  Hypovitaminosis D in medical inpatients. , 1998, The New England journal of medicine.

[2]  R. Eastell.  Treatment of postmenopausal osteoporosis. , 1998, The New England journal of medicine.

[3]  C. Christiansen,et al.  Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. , 1998 .

[4]  J. Renner,et al.  Increased Rate of Fractures and Severe Kyphosis: Sequelae of Living into Adulthood with Cystic Fibrosis , 1998, Annals of Internal Medicine.

[5]  Jacques P. Brown,et al.  Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. , 1997, The New England journal of medicine.

[6]  John Adams,et al.  Gains in Bone Mineral Density with Resolution of Vitamin D Intoxication , 1997, Annals of Internal Medicine.

[7]  J. P. Sy,et al.  Effects of growth hormone treatment in children with cystic fibrosis: the National Cooperative Growth Study experience. , 1997, The Journal of pediatrics.

[8]  W. O'Fallon,et al.  Relationship of Bone Turnover to Bone Density and Fractures , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  S. Ott,et al.  Evaluation of vertebral volumetric vs. areal bone mineral density during growth. , 1997, Bone.

[10]  C. Hill,et al.  Vitamin D Levels in Children With Cystic Fibrosis , 1997, Southern medical journal.

[11]  G. Saggese,et al.  Bone Demineralization in Cystic Fibrosis: Evidence of Imbalance between Bone Formation and Degradation , 1997, Pediatric Research.

[12]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[13]  R. Rizzoli,et al.  Osteoporosis in patients undergoing lung transplantation. , 1996, The European respiratory journal.

[14]  E. Shane,et al.  Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. , 1996, The American journal of medicine.

[15]  D. Bier,et al.  Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients , 1996, Pediatric pulmonology.

[16]  A. Silman,et al.  The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  T. Egan,et al.  Severe osteoporosis before and after lung transplantation. , 1996, Chest.

[18]  D. Thiebaud,et al.  Bone mineral content in cystic fibrosis patients: correlation with fat-free mass. , 1996, Archives of disease in childhood.

[19]  R. Marcus,et al.  Correlates of osteopenia in patients with cystic fibrosis. , 1996, Pediatrics.

[20]  C. Madsen,et al.  Bone density in children and adolescents with cystic fibrosis. , 1996, The Journal of pediatrics.

[21]  E. Engleman,et al.  Inhibition of antigen‐presenting cell function by alendronate in vitro , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  A. Hergenroeder.  Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults. , 1995, The Journal of pediatrics.

[23]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[24]  S. Manolagas.  Bone marrow, cytokines, and bone remodeling , 1995 .

[25]  C. Pichard,et al.  Body composition analysis by dual-energy x-ray absorptiometry in adults with cystic fibrosis. , 1994, Chest.

[26]  R. Henderson,et al.  Kyphosis and fractures in children and young adults with cystic fibrosis. , 1994, The Journal of pediatrics.

[27]  P. Delmas,et al.  Long-term effects of intravenous pamidronate in fibrous dysplasia of bone , 1994, The Lancet.

[28]  R. Marcus,et al.  Osteopenia in adults with cystic fibrosis , 1994 .

[29]  I. Reid,et al.  Bone mineral density and body composition in adult patients with cystic fibrosis. , 1993, Thorax.

[30]  M. Jonckheer,et al.  Low serum bone gamma-carboxyglutamic acid protein concentrations in patients with cystic fibrosis: correlation with hormonal parameters and bone mineral density. , 1993, Hormone research.

[31]  S. Fitzsimmons,et al.  The changing epidemiology of cystic fibrosis. , 1993, The Journal of pediatrics.

[32]  J. Udagawa,et al.  Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis. , 1991, The Journal of pediatrics.

[33]  M. Boechat,et al.  Osteoporosis in cystic fibrosis. , 1988, The Journal of pediatrics.

[34]  M. Hodson,et al.  Vitamin D and parathyroid hormone and bone mineralisation in adults with cystic fibrosis. , 1988, Thorax.

[35]  J. Gamble,et al.  Back pain and spinal deformity in cystic fibrosis. , 1987, American journal of diseases of children.

[36]  M. McKenna,et al.  Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. , 1985, The Quarterly journal of medicine.

[37]  M. Haussler,et al.  Vitamin D metabolites in adolescents and young adults with cystic fibrosis: effects of sun and season. , 1985, The Journal of pediatrics.

[38]  P. di Sant'Agnese,et al.  25-Hydroxycholecalciferol levels in patients with cystic fibrosis. , 1979, The Journal of pediatrics.

[39]  T. Hahn,et al.  Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. , 1979, The Journal of pediatrics.